For their unique cardiac-expression profile, FABP3 has been proposed as an effective biomarker of myocardial injury (7) as FABP3 is readily released from heart muscles into the blood following a heart attack (8, 9, 10). The gene discussed is FABP3; the disease is myocardial infarction.